Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05814562Not ApplicableCompleted

Cardiovascular Precision Medicine & Remote Intervention

Role: collaborator

NCT02726360Completed

Physician Use of Non-English Language Skills in Cancer Care

Role: collaborator

NCT02082886Completed

HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry

Role: lead

NCT03508128Completed

Evaluation of EMI in Patients With Micra Leadless Pacemaker

Role: lead

NCT01230593Not ApplicableCompleted

Chalazion Conservative Treatment Trial

Role: collaborator

All 5 trials loaded